Vera Levina

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. pmc Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties
    Vera Levina
    University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
    PLoS ONE 3:e3077. 2008
  2. pmc Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop
    Vera Levina
    University of Pittsburgh Cancer Institute and Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Cancer Res 70:338-46. 2010
  3. pmc Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation
    Vera Levina
    Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Clin Dev Immunol 2012:173029. 2012
  4. pmc Chemotherapeutic drugs and human tumor cells cytokine network
    Vera Levina
    Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Int J Cancer 123:2031-40. 2008
  5. ncbi request reprint Lung cancer stem cells as a target for therapy
    Elieser Gorelik
    University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Anticancer Agents Med Chem 10:164-71. 2010
  6. pmc Role of eotaxin-1 signaling in ovarian cancer
    Vera Levina
    University of Pittsburgh Cancer Institute, Department of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Clin Cancer Res 15:2647-56. 2009
  7. pmc The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
    Roberto Gomez-Casal
    The University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Cancers (Basel) 7:876-907. 2015
  8. pmc Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production
    Vera Levina
    Department of Medicine and University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Exp Cell Res 314:1605-16. 2008
  9. pmc Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
    Roberto Gomez-Casal
    University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Mol Cancer 12:94. 2013
  10. pmc Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
    Roberto Gomez-Casal
    University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    Oncotarget 6:44306-22. 2015

Detail Information

Publications10

  1. pmc Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties
    Vera Levina
    University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
    PLoS ONE 3:e3077. 2008
    ....
  2. pmc Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop
    Vera Levina
    University of Pittsburgh Cancer Institute and Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Cancer Res 70:338-46. 2010
    ....
  3. pmc Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation
    Vera Levina
    Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Clin Dev Immunol 2012:173029. 2012
    ..Taken together, our findings indicate that Ido1 expression could exert immunological and nonimmunological effects in murine breast tumor cells...
  4. pmc Chemotherapeutic drugs and human tumor cells cytokine network
    Vera Levina
    Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Int J Cancer 123:2031-40. 2008
    ..Thus, a broad disruption of tumor cytokine network is needed to further increase the efficacy of cancer therapy...
  5. ncbi request reprint Lung cancer stem cells as a target for therapy
    Elieser Gorelik
    University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Anticancer Agents Med Chem 10:164-71. 2010
    ..This review provides a summary of some of the developments in the field of lung CSCs targeting and highlights aspects which could help in the drug discovery process...
  6. pmc Role of eotaxin-1 signaling in ovarian cancer
    Vera Levina
    University of Pittsburgh Cancer Institute, Department of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Clin Cancer Res 15:2647-56. 2009
    ..Tumor cell growth and migration can be directly regulated by chemokines. In the present study, the association of CCL11 with ovarian cancer has been investigated...
  7. pmc The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
    Roberto Gomez-Casal
    The University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Cancers (Basel) 7:876-907. 2015
    ..These data highlight the promise of combining ganetespib with IR therapies in the treatment of AC lung tumors. ..
  8. pmc Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production
    Vera Levina
    Department of Medicine and University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Exp Cell Res 314:1605-16. 2008
    ..TRAIL-induced proapoptotic and prosurvival responses correlate with the strength of signaling. TRAIL-induced cytokine production is responsible for its proliferative and prosurvival effects...
  9. pmc Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
    Roberto Gomez-Casal
    University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Mol Cancer 12:94. 2013
    ..CD44, SNAIL and PDGFR-beta are dramatically upregulated in radiation survived cells and might be considered as markers of radiotherapy response in NSCLC. ..
  10. pmc Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
    Roberto Gomez-Casal
    University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    Oncotarget 6:44306-22. 2015
    ..Our data show that HSP90 inhibition can potentiate the effect of radiotherapy and eliminate radioresistant and cisplatin -resistant residual cells, thus it may aid in reducing NSCLC tumor recurrence after fractionated radiotherapy. ..